Across TCGA pan-cancer cohorts, ASB13 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ASB13 data layer compared with 23 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ASB13 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated ASB13 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.

HNSC, CCRCC, and UCEC are the cancer types where ASB13 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Quartile	II,III,IV	0.897	0.403	.003	33	view →
CCRCC	DFS	Tertile	II,III,IV	0.904	0.105	.008	15	view →
UCEC	DFS	Tertile	All	1.000	0.638	.009	10	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ASB13 tumor-vs-normal RNA expression · all ASB13 data types